Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Targeting TGFβ can improve skin immunity in older people.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The skin's immune system helps it regenerate and fight infections.